Dr. Rocío Rojo graduated with honors in Biotechnology Engineering from the Technological Institute of Sonora in 2008. In 2010 she completed the Master of Science in Biotechnology at Tec de Monterrey, focusing on the area of cell therapy. In 2018 she obtained her PhD in Developmental Biology from the Roslin Institute of the University of Edinburgh, United Kingdom; where he carried out immunology projects and developed genetically modified cell and animal models. In 2018 she rejoined the School of Medicine and Health Sciences (EMCS) of Tec de Monterrey (ITESM) doing a postdoctoral stay, participating in the validation of biomarkers in cancer and metabolic diseases. Since 2022 he has been a Research Professor at the EMCS of ITESM and belongs to the Graduate Faculties of the EMCS and Biotechnology; from 2022 to 2024 he contributed to the establishment of the EMCS on the Querétaro campus, and in 2024 he joined the Research Group on Disease Prevention and Precision Medicine on the Chihuahua campus. It collaborates in the dissemination of STEM science, linking high school students with the professional and research area of the EMCS. Dr. Rojo has 17 indexed publications including a first authorship in Nature Communications, >750 citations and an h-index of 12. He has developed and characterized several genetically modified animal models that are part of Jackson Laboratories' collection. She collaborates with national institutions, including CINVESTAV, and international institutions (University of Wisconsin-Madison) and has mentored graduate students in high-impact research projects. Dr. Rojo works in an interdisciplinary way, combining developmental biology, biotechnology and biomedicine to study molecular effectors and signals that are involved in the disruption of homeostasis associated with chronic-degenerative conditions, including senescence and systemic pathologies such as cardiovascular and metabolic diseases and cancer.
Rocio.Rojo@tec.mx
